Evidence map›Paper›PMID 28799710›Full record

Trial reportInfluenza and other respiratory viruses2017

The efficacy of medical masks and respirators against respiratory infection in healthcare workers.

Chandini Raina MacIntyre, Abrar Ahmad Chughtai, Bayzidur Rahman, Yang Peng, Yi Zhang, Holly Seale, Xiaoli Wang, Quanyi Wang

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Influenza and other respiratory viruses, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 5 pooled it
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 5 syntheses or guidelines pooled it, 145 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. In Vitro Assessment ofGlobal challenges (Hoboken, NJ) · 2025
    Article
  10. Article
  11. Ventilation does not affect close-range transmission of influenza virus in a ferret playpen setup.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. The face behind the Covid-19 mask - A comprehensive review.Environmental technology & innovation · 2022
    Review
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 4 countries.

Chandini Raina MacIntyreSchool of Public Health and Community Medicine, University of New South Wales, Sydney, NSW, Australia.
Abrar Ahmad ChughtaiSchool of Public Health and Community Medicine, University of New South Wales, Sydney, NSW, Australia.ORCID 0000-0003-4203-7891
Bayzidur RahmanSchool of Public Health and Community Medicine, University of New South Wales, Sydney, NSW, Australia.
Yang PengThe Beijing Centre for Disease Prevention and Control, Beijing, China.
Yi ZhangThe Beijing Centre for Disease Prevention and Control, Beijing, China.
Holly SealeSchool of Public Health and Community Medicine, University of New South Wales, Sydney, NSW, Australia.
Xiaoli WangThe Beijing Centre for Disease Prevention and Control, Beijing, China.
Quanyi WangThe Beijing Centre for Disease Prevention and Control, Beijing, China.
Beijing Center for Disease Prevention and Control · CNUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe aimed to examine the efficacy of medical masks and respirators in protecting against respiratory infections using pooled data from two homogenous randomised control clinical trials (RCTs).

methodsThe data collected on 3591 subjects in two similar RCTs conducted in Beijing, China, which examined the same infection outcomes, were pooled. Four interventions were compared: (i) continuous N95 respirator use, (ii) targeted N95 respirator use, (iii) medical mask use and (iv) control arm. The outcomes were laboratory-confirmed viral respiratory infection, influenza A or B, laboratory-confirmed bacterial colonisation and pathogens grouped by mode of transmission.

resultsRates of all outcomes were consistently lower in the continuous N95 and/or targeted N95 arms. In adjusted analysis, rates of laboratory-confirmed bacterial colonisation (RR 0.33, 95% CI 0.21-0.51), laboratory-confirmed viral infections (RR 0.46, 95% CI 0.23-0.91) and droplet-transmitted infections (RR 0.26, 95% CI 0.16-0.42) were significantly lower in the continuous N95 arm. Laboratory-confirmed influenza was also lowest in the continuous N95 arm (RR 0.34, 95% CI 0.10-1.11), but the difference was not statistically significant. Rates of laboratory-confirmed bacterial colonisation (RR 0.54, 95% CI 0.33-0.87) and droplet-transmitted infections (RR 0.43, 95% CI 0.25-0.72) were also lower in the targeted N95 arm, but not in medical mask arm.

conclusionThe results suggest that the classification of infections into droplet versus airborne transmission is an oversimplification. Most guidelines recommend masks for infections spread by droplets. N95 respirators, as "airborne precautions," provide superior protection for droplet-transmitted infections. To ensure the occupational health and safety of healthcare worker, the superiority of respirators in preventing respiratory infections should be reflected in infection control guidelines.

Indexed as

Bacterial InfectionsChinaClinical Laboratory TechniquesHealth PersonnelHumansInfection ControlInfluenza, HumanMasksOccupational ExposureRespiratory Tract InfectionsVentilators, MechanicalVirus Diseasesdroplet infectionshealthcare workersinfluenzamasksmedical masksrespirators

Identifiers

PMID28799710
PMCPMC5705692
OpenAlexW2743381712

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.